Understanding which soluble factors are involved in this paracrine signaling and how these factors lead to STAT3 activation via the tumor microenvironment will provide new therapeutic targets for breast carcinomas and other cancers with elevated p-STAT3 levels. The gene discussed is STAT3; the disease is cancer.